Programmed Cell Death via Type IV Photodynamic Therapy Using Internalized Two-Photon Activated Molecular Nanomachines
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c01318 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Thomas S Bradford und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Durham University, South Road, Durham DH1 3LE, United Kingdom. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Biocompatible Materials, Apoptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Welch Foundation, Discovery Institute, Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
Direct photodynamic therapy (PDT) is a growing research area currently being explored as an alternative treatment for various cancers. Compared to traditional, indirect PDT, which exploits the reaction of oxygen with the photosensitizer (PS) to damage specially targeted cells, direct PDT utilizes the PS itself to disrupt the target cell, meaning no reactive oxygen species (ROS) are generated. The activation of Type IV technologies specifically induces a structural change within the photosensitizer, resulting in the activation of its therapeutic effect. In contrast to traditional invasive surgeries, chemotherapy, or ROS-based methods, direct methods of PDT pose significantly less damaging off-target effects. Here, we propose an exciting extension of our prior reported, near-infrared light-activated, molecular nanomachines (MNMs), previously shown to promote cell-specific necrosis via disruption of cellular membranes. We show that the modification of MNMs with polyethylene glycol (PEG), or triphenol phosphonium (TPP+) containing functional groups, allows for homeostatic crossing of the phospholipid bilayer and localization at the mitochondrial membrane. By subsequent activation of the rotor from within the targeted cells, we present the ability to eliminate cells without triggering necrotic cell death, instead inducing an additional mechanism of programmed cell death (PCD), while maintaining the integrity of the cellular membrane, thus enacting a significantly cleaner, more therapeutically favorable mode of inducing cell death. A significant development is in the use of light-activated molecular machines for cancer treatments, with a single MNM-based technology being able to access both necrotic and non-necrotic modes of cell elimination by simply switching the excitation procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Durham University, South Road, Durham DH1 3LE, United Kingdom.
- Department of Chemistry, Rice University, Houston, Texas 77005, United States.
- Department of Chemistry Department of Materials Science and NanoEngineering Rice Advanced Materials Institute and Smalley-Curl Institute NanoCarbon Center, Rice University, Houston, Texas 77005, United States.
ORCID-Profile: Thomas S Bradford, Dongdong Liu, James M Tour, Robert Pal
Förderung
- Welch Foundation
- Discovery Institute
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council
- Royal Society
Zitieren
APA
Bradford, T. S., Liu, D., Tour, J. M., & Pal, R. (2025). Programmed Cell Death via Type IV Photodynamic Therapy Using Internalized Two-Photon Activated Molecular Nanomachines. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c01318
Vancouver
Bradford TS, Liu D, Tour JM, Pal R. Programmed Cell Death via Type IV Photodynamic Therapy Using Internalized Two-Photon Activated Molecular Nanomachines. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c01318
BibTeX
@article{Bradford2025,
author = {Bradford, Thomas S and Liu, Dongdong and Tour, James M and Pal, Robert},
title = {Programmed Cell Death via Type IV Photodynamic Therapy Using Internalized Two-Photon Activated Molecular Nanomachines},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c01318}
}
EUVIMED